|Videos|April 20, 2016
- April 2016
- Volume 2
- Issue 1
Dr. Michael Manns on a Possible Link Between Hepatitis C and Hepatocellular Carcinoma
Author(s)Michael Manns, MD
Michael Manns, MD, explains the possible link between hepatitis C and hepatocellular carcinoma.
Advertisement
Michael Manns, MD, director, Department of Gastroenterology, Hepatology and Endocrinology, Medical School of Hannover in Germany, explains the possible link between hepatitis C and hepatocellular carcinoma.
Manns says that patients who contracted hepatitis C or cirrhosis have showcased a greater risk of developing hepatocellular carcinoma (HCC), though drawing a direct link between the virus and HCC is difficult due to treatment of the virus depleting the potential control group. He concludes by pointing out that if a link is to be drawn between Hepatitis C and HCC, further testing must be done.
Articles in this issue
about 10 years ago
Dr. Anne Covey on Locoregional Therapy in Hepatocellular Carcinomaabout 10 years ago
NCCN Guideline Calls Locoregional Therapy "Curative" for HCCabout 10 years ago
Genetically Modified T-Cell Therapy Cleared for Early Stage HCC Studyabout 10 years ago
Neoadjuvant Sorafenib Induces Major Tumor Necrosis in HCCabout 10 years ago
Committee Recommends Continuation of Phase III Tivantinib Studyabout 10 years ago
Liver Cancer Death Rates Defy Declining Trendsabout 10 years ago
Moving Forward: Examining the Evolving Role of Embolization in HCCabout 10 years ago
Novel Therapies on the Horizon in Hepatocellular CarcinomaAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Dr Cloughesy on Extended Follow-Up Data for Vorasidenib in IDH1/2 Mutant Glioma
2
Bispecific ADC Iza-Bren Extends Survival in Advanced TNBC
3
ASCO 2026 GU Cancer Highlights: Beyond the LBAs
4
FDA Grants Priority Review to Giredestrant for ER+/HER2- Breast Cancer
5